This manuscript evaluates the efficacy of decitabine, a DNA methyltransferase (DNMT) inhibitor, in inducing HbF in healthy human erythroblasts and Townes mice, which are well‐established systems modelling SCD. The gene discussed is DNMT1; the disease is Schnyder corneal dystrophy.